Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Acupuncture in Mild Alzheimer's Disease
NCT05078944Completed
- Sponsor
- Shanghai Institute of Acupuncture, Moxibustion and Meridian
- Start
- Jun 2022
- Primary completion
- Sep 2025
- Countries
- 1
01
Overview
Randomised, single-blind trial in Alzheimer's disease (AD) (2 arms), sponsored by Shanghai Institute of Acupuncture, Moxibustion and Meridian. Primary endpoint: Alzheimer's Disease Assessment Scale-Cognitive 12 Item Subscore at 14 weeks. Started Jun 2022; status: completed.
02
Conditions
Alzheimer's disease (AD)
Beyond the preview
Go deeper on NCT05078944.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05078944.